Literature DB >> 12199713

Sendai virus N-terminal fusion peptide consists of two similar repeats, both of which contribute to membrane fusion.

Sergio G Peisajovich1, Raquel F Epand, Richard M Epand, Yechiel Shai.   

Abstract

The N-terminal fusion peptide of Sendai virus F1 envelope glycoprotein is a stretch of 14 amino acids, most of which are hydrophobic. Following this region, we detected a segment of 11 residues that are strikingly similar to the N-terminal fusion peptide. We found that, when anchored to the membrane by palmitoylation of its N-terminus, this segment (WT-palm-19-33) induces membrane fusion of large unilamellar liposomes to almost the same extent as a segment that includes the N-terminal fusion peptide. The activity of WT-palm-19-33 was dependent on its specific sequence, as a palmitoylated peptide with the same amino-acid composition but a scrambled sequence was inactive. Interestingly, two mutations (G7A and G12A) known to increase F1- induced cell-cell fusion, also increased the homology between the N-terminal fusion peptide and WT-palm-19-33. The role of the amino-acid sequence on the fusogenicity, secondary structure, and mechanism of membrane fusion was analyzed by comparing a peptide comprising both homologous segments (WT 1-33), a G12A mutant (G12A 1-33), a G7A-G12A double mutant (G7A-G12A 1-33), and a peptide with a scrambled sequence (SC 1-33). Based on these experiments, we postulate that replacement of Gly 7 and Gly12 by Ala increases the alpha helical content of the N-terminal region, with a concomitant increase in its fusogenic activity. Furthermore, the dissimilar abilities of the different peptides to induce membrane negative curvature as well as to promote isotropic 31P NMR signals, suggest that these mutations might also alter the extent of membrane penetration of the 33-residue peptide. Interestingly, our results serve to explain the effect of the G7A and G12A mutations on the fusogenic activity of the parent F1 protein in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12199713     DOI: 10.1046/j.1432-1033.2002.03132.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

Review 1.  Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme.

Authors:  Judith M White; Sue E Delos; Matthew Brecher; Kathryn Schornberg
Journal:  Crit Rev Biochem Mol Biol       Date:  2008 May-Jun       Impact factor: 8.250

2.  Conserved glycine residues in the fusion peptide of the paramyxovirus fusion protein regulate activation of the native state.

Authors:  Charles J Russell; Theodore S Jardetzky; Robert A Lamb
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

3.  Cell-cell membrane fusion induced by p15 fusion-associated small transmembrane (FAST) protein requires a novel fusion peptide motif containing a myristoylated polyproline type II helix.

Authors:  Deniz Top; Jolene A Read; Sandra J Dawe; Raymond T Syvitski; Roy Duncan
Journal:  J Biol Chem       Date:  2011-12-14       Impact factor: 5.157

Review 4.  The known unknowns of antigen processing and presentation.

Authors:  Jatin M Vyas; Annemarthe G Van der Veen; Hidde L Ploegh
Journal:  Nat Rev Immunol       Date:  2008-08       Impact factor: 53.106

Review 5.  The three lives of viral fusion peptides.

Authors:  Beatriz Apellániz; Nerea Huarte; Eneko Largo; José L Nieva
Journal:  Chem Phys Lipids       Date:  2014-04-02       Impact factor: 3.329

6.  Interaction of a peptide corresponding to the loop domain of the S2 SARS-CoV virus protein with model membranes.

Authors:  Jaime Guillén; Rodrigo F M De Almeida; Manuel Prieto; José Villalaín
Journal:  Mol Membr Biol       Date:  2009-04-29       Impact factor: 2.857

7.  Membrane insertion of the three main membranotropic sequences from SARS-CoV S2 glycoprotein.

Authors:  Jaime Guillén; Paavo K J Kinnunen; José Villalaín
Journal:  Biochim Biophys Acta       Date:  2008-08-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.